Table 2

Effects of 96-h treatment with different retinoids on the cell cycle distribution of SK-BR-3 cells

Retinoid concentration (m)% of total cellsa
G1SG2
Solvent75.0 ± 1.617.6 ± 2.27.4 ± 0.7
9cRA1081.1 ± 0.510.8 ± 2.88.1 ± 3.1
tRA1082.7 ± 1.210.1 ± 1.87.2 ± 1.2
1090.2 ± 2.24.2 ± 0.65.6 ± 2.1
1092.8 ± 2.32.3 ± 0.74.9 ± 1.7
TTNPB1092.4 ± 1.12.6 ± 0.25.0 ± 1.0
1093.9 ± 1.21.7 ± 0.84.5 ± 0.4
AM801089.5 ± 1.14.7 ± 1.05.7 ± 1.3
1092.0 ± 0.73.2 ± 0.24.8 ± 0.6
AM5801085.5 ± 2.35.4 ± 2.79.1 ± 0.6
1092.0 ± 2.01.8 ± 0.76.2 ± 2.5
CD4171072.1 ± 1.020.3 ± 0.97.7 ± 0.5
1074.8 ± 1.414.6 ± 1.610.6 ± 0.8
CD4371073.2 ± 1.118.9 ± 1.37.9 ± 0.4
1064.9 ± 1.924.4 ± 2.110.6 ± 0.8
Ro 25-73861075.5 ± 1.116.3 ± 1.28.3 ± 2.2
1074.7 ± 1.416.5 ± 1.28.8 ± 0.2
Ro 41-52531071.2 ± 1.517.1 ± 0.711.7 ± 1.0
1073.4 ± 0.613.6 ± 1.513.0 ± 2.1
  • a Mean ± SD of triplicate determinations.